Type 2 diabetes mellitus management in Canada: is it improving?

Area of Science:

• Endocrinology
• Primary Care Medicine
• Diabetes Management

Background:

• Type 2 diabetes mellitus (T2DM) management is complex, requiring multifaceted approaches to achieve glycemic control and reduce vascular risk.
• Canadian primary care physicians play a crucial role in the daily management of T2DM patients.
• Understanding current treatment patterns is essential for identifying areas for improvement.

Purpose of the Study:

• To assess the current management practices for T2DM patients by primary care physicians in Canada.
• To identify the extent to which patients achieve recommended treatment targets for glycated hemoglobin (A1C), low-density lipoprotein cholesterol (LDL-C), and blood pressure (BP).
• To evaluate the utilization of antihyperglycemic, lipid-lowering, and antihypertensive therapies.

Main Methods:

• A cross-sectional survey involving 479 primary care physicians across Canada.
• Data collected on 5123 T2DM patients seen on a single day around World Diabetes Day 2012.
• Analysis of patient data including A1C, LDL-C, BP, and prescribed medications.

Main Results:

• Mean A1C was 7.4%, mean LDL-C was 2.1 mmol/L, and mean BP was 128/75 mm Hg.
• Only 13% of patients achieved the composite triple target (A1C ≤7.0%, LDL-C ≤2.0 mmol/L, BP <130/80 mm Hg).
• Diet counseling was provided to 38%; 87% received antihyperglycemic agents, with increased insulin use compared to previous surveys.

Conclusions:

• A significant treatment gap persists in T2DM management within Canadian primary care.
• Physicians face challenges in achieving glycemic control and global vascular protection for their patients.
• There is an urgent need for practical strategies to enhance T2DM patient management and improve outcomes.